January 2, 2026 · Form 4 insider transaction
Horn Howard sold 3,150 shares of Ultragenyx Pharmaceutical Inc. at $22.84 per share, a transaction worth $71.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.